 |
市场调查报告书
商品编码
1708317
全球体外肺模型市场按类型、应用、最终用户和地区划分Global In Vitro Lung Model Market, By Type, By Application, By End User, By Geography |
||||||
2025 年全球离体肺模型市场价值估计为 3.38 亿美元，预计到 2032 年将达到 8.666 亿美元，2025 年至 2032 年的复合年增长率为 14.4%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 3.38亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 14.40% | 2032年价值预测 | 8.666亿美元 |
体外肺模型是一种旨在模拟人类肺部的生理和解剖特性的实验系统。它广泛应用于药物研发、毒性测试和肺部疾病研究。透过利用体外培养的人类肺细胞和组织，这些模型提供了一种比动物试验相对便宜且有效的替代方法。与动物模型相比，它们也为研究人类肺部生物学和疾病病理学提供了更真实、更可控的环境。未来，组织工程、微流体和其他技术的进步有望帮助开发高度复杂的 3D 肺模型，以更好地重现体内肺微环境。
市场动态：
全球体外肺模型市场受到製药公司对药物研发的投资增加、动物试验的严格规定以及呼吸系统疾病盛行率增加等因素的推动。然而，开发先进的 3D 肺模型的高成本和较短的组织保质期预计会抑制市场成长。同时，微製造和3D生物列印技术的不断发展有望为开发下一代仿生模型提供重大机会。此外，随着人们的注意力集中在开发包含个别患者细胞和组织的个人化肺模型上，市场预计还会扩大。
然而，预计市场参与企业加强研发力度将在预测期内进一步推动市场成长。例如，2024年3月6日，生物技术公司AlveoliX AG在Frontiers Media SA上发表了一项研究，题为“一种多路復用吸入平台，用于模拟慢性阻塞性肺病”，因为美国食品药物管理局（FDA）针对各种呼吸系统疾病（包括气喘、慢性阻塞性肺病（COPD）和纤维化）开发的药物数量。由于美国食品药物管理局(FDA)核准治疗这些严重肺部疾病的吸入药物数量有限，临床前研究已从体内研究转向使用替代的离体人体相关模型，以更准确地预测吸入颗粒的毒性。
本研究的主要特点
- 本研究报告对全球试管内肺模型市场进行了详细分析，并给出了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
- 它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球体外肺模型市场的主要企业概况。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球体外肺模型市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员将透过用于分析全球体外肺模型市场的各种策略矩阵来做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管情景
- 服务产品组合
- PEST分析
- 波特分析
- 併购场景
第四章全球体外肺模型市场-冠状病毒（COVID-19）大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 2020 年至 2032 年全球体外肺模型市场（按类型）
- 2D模型
- 3D模型
6. 全球体外肺模型市场（按应用划分），2020 年至 2032 年
- 药物研发与毒理学研究
- 生理学研究
- 3D模型开发
- 其他的
7. 2020 年至 2032 年全球体外肺模型市场（依最终使用者划分）
- 学术研究所
- 生物製药公司
- 其他的
8. 2020 年至 2032 年全球体外肺模型市场（按地区）
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东
- 非洲
第九章 竞争态势
- Epithelix
- MATTEK
- Lonza
- Emulate
- AlveoliX AG
- Nortis
- CN Bio Innovations Ltd
- MIMETAS
- InSphero
- ATTC Global
- Tissuse GmbH
- Cn Bio Innovations Limited
第 10 章 章节
- 调查方法
- 关于出版商
Global In Vitro Lung Model Market is estimated to be valued at USD 338.0 Mn in 2025 and is expected to reach USD 866.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 14.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 338.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 14.40% | 2032 Value Projection: | USD 866.6 Mn |
In vitro lung models are experimental systems that aim to mimic the physiological and anatomical properties of the human lungs. They are widely used in drug discovery, toxicity testing, and studying lung diseases. By utilizing human lung cells and tissues grown outside of the body, these models offer a relatively affordable and effective alternative to animal testing. They also provide a more realistic and controllable environment to study human lung biology and disease pathology compared to animal models. Going forward, advances in tissue engineering, microfluidics, and other technologies are expected to help develop highly complex 3D lung models that can better recreate the in vivo lung microenvironment.
Market Dynamics:
The global in vitro lung model market is driven by factors such as rising drug R&D investments by pharmaceutical companies, stringent regulations regarding animal testing, and increasing prevalence of respiratory diseases. However, high costs associated with developing advanced 3D lung models and shorter shelf life of tissues are expected to restrain the market growth. Meanwhile, ongoing advances in microfabrication and 3D bioprinting technologies are projected to create significant opportunities for manufacturers to develop next-gen biomimetic models. The market is also anticipated to gain from growing focus on developing personalized lung models incorporating individual patient-derived cells and tissues.
On the other hand, rising research and development by market players is further expected to propel the market growth over the forecast period. For instance, on March 6, 2024, AlveoliX AG, a biotechnology company, published a study in Frontiers Media S.A., a peer-reviewed, open access, scientific journals, entitled "A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip" for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis, due to limited number of U.S. Food and Drug Administration, approved inhaled drugs for these serious lung conditions has led to a shift from in vivo towards the use of alternative in vitro human-relevant models to better predict the toxicity of inhaled particles in preclinical research.
Key features of the study:
- This report provides an in-depth analysis of the global In vitro lung model market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global In vitro lung model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Histogen Inc., OliX Pharmaceuticals, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global In vitro lung model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In vitro lung model market
Detailed Segmentation:
- Global In Vitro Lung Model Market, By Type
- 2D Model
- 3D Model
- Global In Vitro Lung Model Market, By Application
- Drug Discovery & Toxicology Studies
- Physiological Research
- 3D Model Development
- Others
- Global In Vitro Lung Model Market, By End User
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
- Global In Vitro Lung Model Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Company Profiles
- Histogen Inc.
- OliX Pharmaceuticals
- Cipla Limited
- Aclaris Therapeutics, Inc.
- Merck & Co., Inc.
- Daiichi-Sankyo Co., Ltd.
- Johnson and Johnson Services, Inc.
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- PureTech
- Vitabiotics
- Dr. Reddy's Laboratories
- HCell Inc.
- Follica, Inc.
- Ranbaxy Laboratories Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global In Vitro Lung Model Market, By Type
- Global In Vitro Lung Model Market, By Application
- Global In Vitro Lung Model Market, By End User
- Global In Vitro Lung Model Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of lung diseases
- High costs associated with animal models
- Growing preference for 3D lung models over 2D models
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global In Vitro Lung Model Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global In Vitro Lung Model Market, By Type, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 2D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- 3D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
6. Global In Vitro Lung Model Market, By Application, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Discovery & Toxicology Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Physiological Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- 3D Model Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
7. Global In Vitro Lung Model Market, By End User, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
8. Global In Vitro Lung Model Market, By Region, 2020-2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Epithelix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MATTEK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Emulate
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AlveoliX AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nortis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- CN Bio Innovations Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MIMETAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- InSphero
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ATTC Global
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Tissuse GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cn Bio Innovations Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
